Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder.

about

Intravesical liposome therapy for interstitial cystitis.MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin-A injection.[Overactive bladder-which treatment when?]The Expanding Therapeutic Utility of Botulinum Neurotoxins.

P2860

Q39160922-4EE28E46-BEAD-42A9-B31A-1C8AA696A38D Q46367789-F276A2C7-0EB7-42AF-8FB8-372D316B2B2A Q50085927-504E3E57-3E87-4885-8594-4DAF47FF0910 Q55105284-D5AAD5B0-8422-4482-9A4F-46E00795DB55

P2860

Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder.

Item

http://www.wikidata.org/entity/Q38792373

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Past, Present and Future of Ch ...... eatment of Overactive Bladder.

@en

type

Item

label

Past, Present and Future of Ch ...... eatment of Overactive Bladder.

@en

prefLabel

Past, Present and Future of Ch ...... eatment of Overactive Bladder.

@en

P1476

Past, Present and Future of Ch ...... eatment of Overactive Bladder.

@en

P2093

Christopher J Chermansky

http://www.w3.org/2001/XMLSchema#string

Mahendra Kashyap

http://www.w3.org/2001/XMLSchema#string

Michael Chancellor

http://www.w3.org/2001/XMLSchema#string

Naoki Yoshimura

http://www.w3.org/2001/XMLSchema#string

Pradeep Tyagi

http://www.w3.org/2001/XMLSchema#string

P2860

Bladder uptake of liposomes after intravesical administration occurs by endocytosis

Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium.

Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder.

Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells.

Studies of the mechanistic details of the pH-dependent association of botulinum neurotoxin with membranes

Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation.

Radiofrequency sacral rhizotomy for the management of intolerable neurogenic bladder in spinal cord injured patients.

Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury.

Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome.

Spontaneous Recovery of Reflex Voiding Following Spinal Cord Injury Mediated by Anti-inflammatory and Neuroprotective Factors.

P304

982-990

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2016.11.092

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27871929

http://www.w3.org/2001/XMLSchema#string

P932

5386789

http://www.w3.org/2001/XMLSchema#string

Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder.

about

P2860

P2860

Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932